Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 19:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.3
- Combined market value
- SAR 33.49T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | SAR 114.1B | SAR 754.66 | 4.20% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | SAR 66.6B | SAR 2,381.43 | 1.85% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | SAR 777.2B | SAR 626.59 | 1.15% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.1 | SAR 185.4B | SAR 657.51 | 1.15% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | SAR 23B | SAR 162.91 | 0.74% up | 13% up | ||
| 106 | Halozyme TherapeuticsHALO · Health Care | 7.5 | SAR 39.2B | SAR 344.00 | 4.27% down | 39% up | ||
| 107 | United TherapeuticsUTHR · Health Care | 7.5 | SAR 89.9B | SAR 2,110.88 | 2.53% down | 22% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | SAR 1.88T | SAR 1,061.70 | 1.04% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | SAR 126.7B | SAR 6,372.14 | 2.21% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | SAR 118.3B | SAR 191.90 | 0.37% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.6 | SAR 171.6B | SAR 1,501.94 | 0.79% down | 16% up | ||
| 112 | West Pharmaceutical ServicesWST · Health Care | 8.9 | SAR 102.8B | SAR 1,475.68 | 2.63% down | 57% up | ||
| 113 | PenumbraPEN · Health Care | 9.0 | SAR 47.3B | SAR 1,200.00 | 0.21% down | 15% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.3 | SAR 26.6B | SAR 242.88 | 4.48% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | SAR 42.8B | SAR 272.74 | 0.05% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.5 | SAR 17.5B | SAR 182.26 | 3.28% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | SAR 34.5B | SAR 1,483.60 | 0.64% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.8 | SAR 223.4B | SAR 388.57 | 1.56% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.9 | SAR 27.8B | SAR 353.21 | 0.93% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | SAR 495.6B | SAR 1,954.57 | 2.87% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.1 | SAR 26.7B | SAR 506.69 | 0.81% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.8 | SAR 28.4B | SAR 215.68 | 0.75% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 11.9 | SAR 23.3B | SAR 357.32 | 2.99% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | SAR 204B | SAR 2,589.47 | 1.16% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.1 | SAR 531.2B | SAR 1,532.38 | 2.95% down | 24% down | ||
| 126 | argenxARGX · Health Care | 14.2 | SAR 221.6B | SAR 3,523.90 | 0.19% down | 2% up | ||
| 127 | BillionToOneBLLN · Health Care | 14.3 | SAR 16.3B | SAR 342.13 | 0.36% down | 4% down | ||
| 128 | RepligenRGEN · Health Care | 14.7 | SAR 40.7B | SAR 637.28 | 1.61% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 15.9 | SAR 36.8B | SAR 243.48 | 1.83% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | SAR 146.2B | SAR 254.34 | 1.26% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.7 | SAR 17.3B | SAR 107.02 | 0.25% up | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.3 | SAR 158.2B | SAR 1,091.24 | 0.49% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | SAR 4.52T | SAR 5,073.98 | 2.17% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.3 | SAR 74.9B | SAR 553.87 | 1.74% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.5 | SAR 28.9B | SAR 424.43 | 2.75% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.1 | SAR 63.1B | SAR 962.13 | 5.12% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.5 | SAR 21.7B | SAR 1,082.80 | 3.36% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.5 | SAR 14.8B | SAR 168.80 | 1.94% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.0 | SAR 35B | SAR 1,181.94 | 0.08% down | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.4 | SAR 52.1B | SAR 880.58 | 0.72% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.5 | SAR 338.4B | SAR 1,721.78 | 1.52% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.4 | SAR 57.2B | SAR 293.63 | 0.35% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.0 | SAR 17.7B | SAR 393.14 | 2.65% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.6 | SAR 303.2B | SAR 749.26 | 1.50% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | SAR 30.4B | SAR 438.77 | 1.73% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.1 | SAR 118.6B | SAR 540.48 | 20.28% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.3 | SAR 26.1B | SAR 24.50 | 2.50% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.6 | SAR 26.9B | SAR 193.45 | 0.50% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 177 | SAR 30.5B | SAR 467.15 | 2.06% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 263 | SAR 38.7B | SAR 453.55 | 0.18% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1085 | SAR 14.3B | SAR 147.26 | 2.31% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1805 | SAR 27.3B | SAR 306.19 | 2.04% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2390 | SAR 18.3B | SAR 324.16 | 2.91% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3426 | SAR 106.2B | SAR 146.51 | 0.85% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 19:08 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of SAR 33.49T as of 19 Nov 2026, 19:08 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.